MedPath

KTP vs CO2 Laser for the Treatment of Laryngeal Carcinoma

Not Applicable
Conditions
Laryngeal Neoplasms
Interventions
Device: CO2 laser
Device: KTP laser
Registration Number
NCT02672904
Lead Sponsor
Kaplan Medical Center
Brief Summary

comparison results of treatment of early stage glottic cancer between two methods of surgical treatment - CO2 laser and KTP laser

Detailed Description

Randomized controlled double-blinded study. The study group includes patients diagnosed with early glottic cancer, either carcinoma in situ or T1a-b,N0M0 squamous cell carcinoma.

Patients will undergo examination and treatment and at least 3 years of follow-up.

40 cancer patients will be included. The participants will be randomly divided into two groups: the first will be treated by KTP laser and the second by CO2 laser.

The patients will be blinded to the method of treatment. To enable double-blinding, the investigator performing the surgery would be the only one knowing which research group the patient belongs to. The investigator in charge of collecting the data after the operation will be blinded to the treatment method.

Each participant will undergo pre-operative evaluation and follow-up after surgery in both arms.

Preoperative evaluation will include:

* Voice Handicap Index questionnaire

* GRBAS - subjective assessment of voice quality.

* Video-stroboscopy of vocal cords

* Voice Analysis .

Follow-up after surgery:

* Visit 6 weeks after surgery (± two weeks), and then every three months (± 6 weeks).

* repeated full evaluation (questionnaire, GRBAS, Stroboscopy, voice analysis) in 30 weeks of follow up and 3 years of follow up.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients with pre-operative diagnosis of squamous cell cancer of the vocal cords at an early stage ( Carcinoma in situ or T1-glottic carcinoma).
Exclusion Criteria
  • Patients who underwent previous significant vocal cords surgical intervention , or irradiation.
  • Contraindications to any endoscopic surgical treatment (general health condition, patient refusal, technical surgical difficulties)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CO2 laserCO2 laserPatients undergoing endoscopic treatment with CO2 laser
KTP laserKTP laserPatients undergoing endoscopic treatment with KTP laser
Primary Outcome Measures
NameTimeMethod
number of surgical interventions3 years

total number of surgical interventions needed to eliminate the disease

Cure rates in terms of local, regional or distant recurrence events3 years after last intervention

evidence of malignant disease in the larynx, cervical lymph nodes or distant metastases

Overall survival and disease-dependent survival over a period of at least 3 years3 years after last intervention
voice quality results In the short term6 month after last intervention

objective measurement- voice lab analysis, and subjective measurement- Voice Handicap Index questionnaire

voice quality results In the long term3 years after last intervention

objective measurement- voice lab analysis, and subjective measurement- Voice Handicap Index questionnaire

Duration of surgeryintraoperative

total time (minutes) of surgical procedure

Recovery time after surgeryup to 3 years

recovery in terms of overall function, breathing, swallowing and vocal communication

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kapkan medical center

🇮🇱

Rehovot, Israel

© Copyright 2025. All Rights Reserved by MedPath